Oscar Health, Inc.
OSCR · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $1 | $1 |
| - Cash | $2 | $2 | $2 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $0 | -$1 | $0 |
| Revenue | $9 | $6 | $4 | $2 |
| % Growth | 56.5% | 42.1% | 114.8% | – |
| Gross Profit | $9 | $6 | $4 | $2 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $0 | -$0 | -$1 | -$1 |
| % Margin | 1% | -3.6% | -13.9% | -28.7% |
| Net Income | $0 | -$0 | -$1 | -$1 |
| % Margin | 0.3% | -4.6% | -14.7% | -29.8% |
| EPS Diluted | 0.096 | -1.22 | -2.87 | -3.19 |
| % Growth | 107.8% | 57.5% | 10% | – |
| Operating Cash Flow | $1 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | -$0 | $0 | -$0 |